February 06, 2015
A German medical device manufacturer and two executives have entered into a $6 million agreement with the U.S. Food and Drug Administration that ends a New Hampshire federal suit accusing the company of maintaining poor quality control at three subsidiaries, temporarily pulling some products from its New Hampshire unit.